John L. Brottem sold $5,531 of OM
General Counsel at Outset Medical, Inc.. 6,145 shares at an average of $0.90, traded Feb 18, 2025, filed Feb 19, 2025.
Score components
- +15RoleOfficer
- 0Trade size$6k at market
- 0Share of holdings soldSold 3.4% of holdings
- +8Cluster2 insiders selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001484612-25-000031, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Feb 18, 2025 | SOpen-market sale Common Stock | -6,145 | $0.90 | $5,531 | 175,043 | Feb 19, 2025 |
Related signals
Other insiders at Outset Medical, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 41Moderate | OMbuy Outset Medical, Inc. | Braden Michael Leonard owner | $870k 244,909 shares | +10% | |
| 15Weak | OMsell Outset Medical, Inc. | John L. Brottem General Counsel | $9,521 2,842 shares | -8% | |
| 27Weak | OMsell Outset Medical, Inc. | John L. Brottem General Counsel | $54k 10,494 shares | -23% | |
| 15Weak | OMsell Outset Medical, Inc. | John L. Brottem General Counsel | $956 224 shares | -0% | |
| 35Weak | Outset Medical, Inc. | Karen Drexler director | $6,765 1,548 shares | -13% | |
| 30Weak | Outset Medical, Inc. | John L. Brottem General Counsel | $1,785 388 shares | -1% | |
| 30Weak | Outset Medical, Inc. | Marc Nash EVP Operations R&D & Service | $1,136 247 shares | -1% | |
| 40Moderate | Outset Medical, Inc. | Leslie Trigg Chair and CEO | $4,214 916 shares | -1% | |
| 30Weak | Outset Medical, Inc. | John L. Brottem General Counsel | $4,933 383 shares | -1% | |
| 30Weak | Outset Medical, Inc. | Marc Nash SVP Operations and R&D | $3,130 243 shares | -1% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.